A wide selection of reports covering top issues in pharma and health care.
Should Avastin keep its Breast Cancer Indication?
February 3, 2011
Physician reactions to the FDA's decision to rescind the indication for Avastin in the treatment of breast cancer.
Utility of Social Networks for Physicians and Life Sciences
January 10, 2011
How physicians are using social networks, and how life science companies can reach them.
Potential Replacements for Coumadin (warfarin)
November 24, 2010
Physicians discuss their awareness and understanding of potential replacements for coumadin, as well as barriers to prescribing.
FDA-Required REMS a Potential Barrier
October 21, 2010
Physicians perspectives on the FDA-required Erythropoiesis-Stimulating Agents (ESAs) risk evaluation and mitigation strategy (REMS) program.
Ticagrelor is Likely to Affect the Standard of Care
August 25, 2010
Insight into evolving trends of CML.
See what Sermo Business Solutions can do for you. Contact Us